Picture of Sartorius AG logo

SRT Sartorius AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Momentum

Relative Strength (%)
1m+5.54%
3m+2.53%
6m-1.94%
1yr-21.02%
Volume Change (%)
10d/3m-9.73%
Price vs... (%)
52w High-12.73%
50d MA+7.31%
200d MA+11.44%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)49.9
PEG Ratio (f)3.63
EPS Growth (f)15.94%
Dividend Yield (f)0.4%
Valuation (ttm)IndustryMarket
Price to Book Value9.53
Price to Tang. Bookn/a
Price to Free Cashflow67.04
Price to Sales5.8
EV to EBITDA30.21

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5.69%
Return on Equity10.12%
Operating Margin14.11%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m1,826.972,335.663,449.24,174.73,395.73,641.774,104.1616.74%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+25.83+39.81+37.69+117.3-55.78+11.39+29.81n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sartorius AG EPS forecast chart

Profile Summary

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
May 28th, 1990
Public Since
April 1st, 1999
No. of Employees
14,614
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
de flag iconXETRA
Shares in Issue
68,415,862
Blurred out image of a map
Address
Otto-Brenner-Str. 20, GOETTINGEN, 37079
Web
https://www.sartorius.com/
Phone
+49 5513080
Contact
Petra Kirchhoff
Auditors
KPMG AG Wirtschaftsprufungsgesellschaft

SRT Share Price Performance

Latest News for SRT

Upcoming Events for SRT

Sartorius AG Annual Shareholders Meeting

Sartorius AG Annual Shareholders Meeting

Dividend For SOAGY.PK - 0.1596 USD

Dividend For SSSGY.PK - 0.1572 USD

Dividend For SATG.DE - 0.7300 EUR

Dividend For SATG_p.DE - 0.7400 EUR

Q1 2024 Sartorius AG Earnings Release

Q2 2024 Sartorius AG Earnings Release

FAQ